-
Posted: October 21st, 2019, 2:00pm GMT
Condition: Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma
Intervention: Drug: Sodium Thiosulfate (STS)
Sponsors: TRPHARM; Fennec Pharma; Klinar CRO
Available
-
Posted: September 18th, 2019, 2:00pm GMT
Conditions: Hepatocellular Carcinoma; Hepatoblastoma
Interventions: Genetic: TEGAR T cells; Drug: Cytoxan; Drug: Fludarabine
Sponsors: Baylor College of Medicine; Texas Children's Hospital; The Methodist Hospital System
Not yet recruiting
-
Posted: May 22nd, 2019, 2:00pm GMT
Conditions: Childhood Liver Cancer; Liver Malignant Tumors; Embryonal Sarcoma of Liver (Disorder); Hepatoblastoma; Hepatocellular Carcinoma; Rhabdoid Tumor of Liver
Intervention:
Sponsor: University of Pittsburgh
Recruiting
-
Posted: April 12th, 2019, 2:00pm GMT
Condition: Pulmonary Malformation
Interventions: Device: 3D printed model; Other: Control group
Sponsor: Hospices Civils de Lyon
Not yet recruiting
-
Posted: August 24th, 2018, 2:00pm GMT
Conditions: Hepatoblastoma; Hepatic Hemangioendothelioma
Intervention: Diagnostic Test: PIVKA-II
Sponsors: Shanghai Children's Medical Center; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Chidren's Hospital of Fudan University; Chongqing Children's Hospital, Chongqing Medical University; Children’s Hospital of Nanjing Medical University; Qilu Children's Hospital of Shandong University; Anhui Children's Hospital; The First Affiliated Hospital of Anhui Medical University; Zhengzhou Children's Hospital
Recruiting
-
Posted: August 7th, 2018, 2:00pm GMT
Conditions: Pediatric Solid Tumor; Germ Cell Tumor; Retinoblastoma; Hepatoblastoma; Wilms Tumor; Rhabdoid Tumor; Carcinoma; Osteosarcoma; Ewing Sarcoma; Rhabdomyosarcoma; Synovial Sarcoma; Clear Cell Sarcoma; Malignant Peripheral Nerve Sheath Tumors; Desmoplastic Small Round Cell Tumor; Soft Tissue Sarcoma; Neuroblastoma
Interventions: Biological: second generation 4-1BBζ EGFR806-EGFRt; Biological: second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
Sponsor: Seattle Children's Hospital
Recruiting
-
Posted: April 25th, 2018, 2:00pm GMT
Condition: Cancer
Interventions: Drug: Gemcitabine; Drug: Nab-paclitaxel
Sponsors: Emory University; Celgene Corporation
Recruiting
-
Posted: July 11th, 2017, 2:00pm GMT
Conditions: Advanced Malignant Solid Neoplasm; Ann Arbor Stage III Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; EZH2 Gene Mutation; Low Grade Glioma; Recurrent Central Nervous System Neoplasm; Recurrent Ependymoma; Recurrent Ewing Sarcoma; Recurrent Glioma; Recurrent Hepatoblastoma; Recurrent Hodgkin Lymphoma; Recurrent Langerhans Cell Histiocytosis; Recurrent Malignant Germ Cell Tumor; Recurrent Malignant Glioma; Recurrent Malignant Solid Neoplasm; Recurrent Medulloblastoma; Recurrent Neuroblastoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Osteosarcoma; Recurrent Peripheral Primitive Neuroectodermal Tumor; Recurrent Rhabdoid Tumor; Recurrent Rhabdomyosarcoma; Recurrent Soft Tissue Sarcoma; Refractory Hodgkin Lymphoma; Refractory Langerhans Cell Histiocytosis; Refractory Malignant Germ Cell Tumor; Refractory Malignant Glioma; Refractory Malignant Solid Neoplasm; Refractory Medulloblastoma; Refractory Neuroblastoma; Refractory Non-Hodgkin Lymphoma; Refractory Osteosarcoma; Refractory Peripheral Primitive Neuroectodermal Tumor; Refractory Rhabdoid Tumor; Refractory Soft Tissue Sarcoma; Rhabdoid Tumor; SMARCA4 Gene Inactivation; SMARCB1 Gene Inactivation; Stage III Soft Tissue Sarcoma AJCC v7; Stage IV Soft Tissue Sarcoma AJCC v7; Wilms Tumor
Interventions: Other: Laboratory Biomarker Analysis; Drug: Tazemetostat
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: January 11th, 2017, 3:00pm GMT
Conditions: Hepatoblastoma; Carcinoma, Hepatocellular
Interventions: Drug: Cisplatin; Drug: Doxorubicin; Drug: Carboplatin; Drug: 5Fluorouracil; Drug: Vincristine; Drug: Etoposide; Drug: Irinotecan; Drug: Gemcitabine; Drug: Oxaliplatin; Drug: Sorafenib
Sponsors: University of Birmingham; Fundació Institut Germans Trias i Pujol; University of Padua; University of Newcastle Upon-Tyne; University Hospital Munich; University Hospital, Bonn; University of Kiel; University Hospital Tuebingen; Medical University of Gdansk
Recruiting
-
Posted: March 18th, 2015, 2:00pm GMT
Conditions: Retinoblastoma; Clear Cell Sarcoma; Renal Cell Carcinoma; Rhabdoid Tumor; Wilms Tumor; Hepatoblastoma; Neuroblastoma; Germ Cell Tumors; Ewings Sarcoma; Non-rhabdomyosarcoma Soft Tissue Sarcoma; Osteosarcoma; Rhabdomyosarcoma
Interventions: Drug: Simvastatin; Drug: Cyclophosphamide; Drug: Topotecan; Drug: Myeloid growth factor
Sponsors: Emory University; Children's Healthcare of Atlanta
Recruiting
-
Posted: March 5th, 2013, 3:00pm GMT
Condition: Refractory and/or Relapsed Metastatic Solid Tumors
Interventions: Drug: Cyclophosphamide; Drug: Fludarabine; Radiation: low dose total body irradiation; Drug: Melphalan; Drug: Tacrolimus
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Recruiting
-
Posted: January 6th, 2012, 3:00pm GMT
Conditions: Ewing's Family Tumors; Renal Tumors; Hepatoblastoma; Rhabdomyosarcoma; Soft Tissue Sarcoma; Primary Malignant Brain Neoplasms; Retinoblastoma; Medulloblastoma; Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET); Atypical Teratoid/Rhabdoid Tumor (AT/RT); CNS Tumors; Germ Cell Tumors
Interventions: Drug: Ifosfamide; Drug: Etoposide; Drug: Mesna; Biological: G-CSF; Drug: Busulfan; Drug: Melphalan; Drug: Thiotepa; Biological: Autologous stem cell infusion; Radiation: Radiation; Drug: Carboplatin; Drug: Paclitaxel; Procedure: Leukapheresis; Drug: Anti-seizure prophylaxis; Drug: Ursodiol
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting